A more comprehensive understanding of the molecular mechanisms through which METTL14 modulates immune responses, in conjunction with the development of selective inhibitors, has the potential to uncover new therapeutic avenues, facilitating the advancement of more targeted and efficacious immunotherapy strategies for liver cancer (33). The gene discussed is METTL14; the disease is liver cancer.